PONTIERI, FRANCESCO ERNESTO
 Distribuzione geografica
Continente #
NA - Nord America 5.558
EU - Europa 1.433
AS - Asia 950
SA - Sud America 41
AF - Africa 31
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.019
Nazione #
US - Stati Uniti d'America 5.523
IT - Italia 598
SG - Singapore 411
IN - India 261
UA - Ucraina 198
CN - Cina 173
FI - Finlandia 146
SE - Svezia 146
DE - Germania 85
GB - Regno Unito 48
RU - Federazione Russa 42
BG - Bulgaria 40
AR - Argentina 33
IE - Irlanda 32
CA - Canada 29
TG - Togo 26
ID - Indonesia 22
IL - Israele 22
BE - Belgio 16
TR - Turchia 16
FR - Francia 15
NL - Olanda 13
CH - Svizzera 10
PK - Pakistan 9
ES - Italia 8
PT - Portogallo 7
RO - Romania 7
GR - Grecia 6
JP - Giappone 6
MX - Messico 6
AU - Australia 5
CZ - Repubblica Ceca 5
IR - Iran 5
BR - Brasile 4
HK - Hong Kong 4
IQ - Iraq 4
SA - Arabia Saudita 4
CY - Cipro 3
KR - Corea 3
LI - Liechtenstein 3
CL - Cile 2
CO - Colombia 2
LB - Libano 2
LT - Lituania 2
VN - Vietnam 2
ZA - Sudafrica 2
AL - Albania 1
AT - Austria 1
DK - Danimarca 1
EG - Egitto 1
EU - Europa 1
HU - Ungheria 1
KZ - Kazakistan 1
MU - Mauritius 1
NO - Norvegia 1
PL - Polonia 1
SC - Seychelles 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 8.019
Città #
Fairfield 883
Chandler 464
Woodbridge 406
Ashburn 393
Houston 377
Seattle 348
Cambridge 307
Singapore 306
Wilmington 259
Rome 239
Ann Arbor 176
Princeton 151
Dearborn 123
Santa Clara 120
Plano 112
Lawrence 102
San Paolo di Civitate 90
Jacksonville 86
San Diego 79
Boston 78
Millbury 64
Beijing 48
Andover 42
New York 40
Sofia 40
Helsinki 39
Boardman 38
Des Moines 32
Federal 32
Norwalk 31
Falkenstein 30
Dublin 28
Lomé 26
Milan 24
Toronto 24
Jakarta 22
Falls Church 20
Fremont 20
Hefei 16
Brussels 15
Kunming 14
Nanjing 14
Perm 11
Jinan 10
Moscow 10
Bühl 9
Istanbul 9
Los Angeles 9
Ahmedabad 8
Bremen 8
Karachi 8
Mannheim 8
San Mateo 7
Southend 7
Ankara 6
Guangzhou 6
Nanchang 6
Oxford 6
Redmond 6
Bologna 5
Indiana 5
London 5
Redwood City 5
Zhengzhou 5
Zurich 5
Albano Laziale 4
Florence 4
Frankfurt am Main 4
Hong Kong 4
Laurel 4
Melbourne 4
Mexico City 4
Phoenix 4
Prague 4
Terracina 4
Bacu Abis 3
Berlin 3
Bonndorf 3
Buffalo 3
Fasano 3
Fuzhou 3
Hyderabad 3
Lappeenranta 3
Melegnano 3
Messina 3
Mestre 3
Naples 3
Ningbo 3
Potenza Picena 3
Provo 3
Pune 3
Reggio Emilia 3
Shenyang 3
Terrassa 3
Trevenzuolo 3
Alife 2
Amsterdam 2
Bern 2
Brixen 2
Casalnuovo di Napoli 2
Totale 6.032
Nome #
Differential Effect of Acute Administration of Clozapine or Haloperidol on Local Cerebral Glucose Utilization in the Rat 136
An exploratory case-control study on spinal and bulbar forms of amyotrophic lateral sclerosis in the province of Rome. 105
Phosphorylated α-synuclein immunoreactivity in nerve fibers from minor salivary glands in Parkinson's disease 102
Minocycline in amyotrophic lateral sclerosis: a pilot study 99
Drug Choices and Advancements for Managing Depression in Parkinson`s Disease 99
Opioid-dopamine interaction in planaria: a behavioral study 94
Prodromal non-motor symptoms of Parkinson's disease 94
Relationship between123I ioflupane SPECT and expression of DAT in peripheral mononuclear cells. 93
Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment. Frequency and neuropsychological/neuropsychiatric correlates 90
Intensity-dependent facial emotion recognition and cognitive functions in Parkinson's disease. 89
Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease 86
123I ioflupane SPECT correlates with Dopamine trasporter in peripheral mononuclear cells. 84
Psychiatric profile of motor subtypes of de novo drug-naïve Parkinson's disease patients 84
Botulinum toxin type A for Holmes tremor secondary to thalamic hemorrhage 83
Bupropion abates dopamine agonist-mediated compulsive behaviors in Parkinson's disease. 82
Neuropsychiatric and cognitive symptoms and body side of onset of parkinsonism in unmedicated Parkinson's disease patients 82
Alpha-synuclein in salivary gland as biomarker for Parkinson's disease 82
The Dopaminergic System in Peripheral Blood Lymphocytes: From Physiology to Pharmacology and Potential Applications to Neuropsychiatric Disorders 80
Alterations of opiate receptor binding in MPTP-induced hemiparkinsonian monkeys. 80
The impact of extended release dopamine agonists on prescribing patterns for therapy of early Parkinson’s disease: an observational study. 80
Supine hypertension in Parkinson’s disease and multiple system atrophy 79
Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease 77
Entacapone in elderly Parkinsonian patients experiencing levodopa-related wearing-off: a pilot study 76
The recognition of facial emotion expressions in Parkinson's disease 75
Dopamine transporter immunoreactivity in peripheral blood lymphocytes discriminates Parkinson's disease from essential tremor 74
Orthostatic hypotension acutely impairs executive functions in Parkinson's disease 74
Reduced dopamine in peripheral blood lymphocytes in Parkinson's disease 74
Dopamine release in striatal slices of rats previously submitted to electroconvulsive shock 73
Dopamine receptor mRNAs in the rat lymphocytes 73
Electroconvulsive shock blocks the opioid-mediated inhibition of dopamine release in rat striatal slices 73
Amantadine in parkinsonian patients unresponsive to levodopa: a pilot study 73
Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders 72
Adrenal dysregulation in amyotrophic lateral sclerosis. 72
Behavioral sensitization to heroin by cannabinoid pretreatment in the rat. 71
Neuropharmacology of cannabinoid system: from basic science to clinical applications. 71
Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression 69
Behavioral sensitization to WIN55212.2 in rats pretreated with heroin 69
Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease 69
Rasagiline for dysexecutive symptoms during wearing-off in parkinson's disease: a pilot study. 69
Treatment with 6-hydroxydopamine in planaria (Dugesia gonocephala s.l.): morphological and behavioral study. 68
Blood Dendritic Cell Frequency Declines in Idiopathic Parkinson's Disease and Is Associated with Motor Symptom Severity 67
Switch from rasagiline to safinamide in fluctuating Parkinson’s disease patients. a retrospective, pilot study 67
Dopamine transporter immunoreactivity in peripheral blood lymphocytes in multiple system atrophy 67
Dopamine transporter immunoreactivity in peripheral blood mononuclear cells in amyotrophic lateral sclerosis 66
Functional correlates of nicotine administration: similarity with drugs of abuse. 66
Sociodemographic, neuropsychiatric and cognitive characteristics of pathological gambling and impulse control disorders NOS in Parkinson's disease 66
Dopaminergic system in peripheral blood mononuclear cells in Parkinson's disease 66
Choline acetyltransferase of the common type immunoreactivity in the rat brain following different heroin treatments: A pilot study 66
Effects of the intravenous administration of [Lys7]dermorphin on local cerebral glucose utilization in the rat. 66
Yawning in Parkinson's disease. 65
Intravenous cocaine, morphine and amphetamine preferentially increase extracellular dopamine in the 'shell' as compared to the 'core' of the rat nucleus accumbens. 65
Age at Onset Influences Progression of Motor and Non-Motor Symptoms during the Early Stage of Parkinson’s Disease: A Monocentric Retrospective Study 64
Dopaminergic drug-induced modulation of the expression of the dopamine transporter in peripheral blood lymphocytes in Parkinson's disease 64
Alexithymia Is a Non-Motor Symptom of Parkinson Disease 64
Central and peripheral dopamine transporter reduction in Parkinson's disease 63
Hedonic tone and its mood and cognitive correlates in Parkinson's disease. 62
Drug addiction as a disorder of associative learning: role of nucleus accumbens shell/extended amygdala dopamine 61
Validation of the Canadian occupational performance measure in Italian Parkinson’s disease clients 61
Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs 60
Amyotrophic lateral sclerosis and sports: A case-control study 60
The potential prognostic role of cardiovascular autonomic failure in α-synucleinopathies. 60
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life 60
Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study 60
Riluzole in cerebellar ataxia: A randomized, double-blind, placebo-controlled pilot trial 59
Heroin sensitization induces circumventricular organ activation in the rat brain 59
Intravenous morphine increases glucose utilization in the shell of the rat nucleus accumbens 59
Metabolic mapping of the synergism between MK-801 and SKF 38393 in rats with unilateral lesions of the dopaminergic nigrostriatal pathway 59
null 59
Dopamine receptor mRNAs in the rat lymphocytes. 58
Psychostimulant drugs increase glucose utilization in the shell of the rat nucleus accumbens 57
Functional correlates of repeated administration of cocaine and apomorphine in the rat 57
Caregiver burden and its related factors in advanced Parkinson's disease: data from the predict study 57
The early course of affective and cognitive symptoms in de novo patients with Parkinson's disease 57
The PRIAMO study: background, methods and recruitment 57
Detecting nocturnal hypertension in Parkinson's disease and multiple system atrophy: proposal of a decision-support algorithm 56
Selective metabolic activation by apomorphine in the striosomes of denervated striatum in MPTP-induced hemiparkinsonian monkeys. 55
Type-B monoamine oxidase inhibitors in neurological diseases: clinical applications based on preclinical findings 54
Increased lymphocyte dopamine beta-hydroxylase immunoreactivity in Alzheimer's disease: compensatory response to cholinergic deficit? 54
Hippocampal abnormalities and memory deficits in Parkinson disease: A multimodal imaging study 54
null 54
Functional correlates of heroin sensitization in the rat brain 52
Changes in neuropeptide FF and NPY immunohistochemical patterns in rat brain under heroin treatment 52
Regional cortical thickness and cognitive functions in non-demented Parkinson's disease patients: a pilot study 52
Metabolic mapping of the effects of intravenous methamphetamine administration in freely moving rats 51
Heroin sensitization as mapped by c-Fos immunoreactivity in the rat striatum 51
Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature 51
Rotigotine for anxiety during wearing-off in Parkinson's disease with dementia 51
Effects of Haloperidol on the expression of lymphocyte dopamine receptor mRNA in the rat 50
Metabolic mapping of the effects of Win 55212-2 intravenous administration in the rat 49
Increased cChAT immunoreactivity in basal forebrain of heroin sensitized rats 49
Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism 49
Priming as a model of behavioural sensitization. 48
Plasma-exchange responsive delayed pseudochoreoathetosis in a patient with anti-Hu neuronopathy 48
The tolerability, safety and efficacy of safinamide in elderly Parkinson's disease patients: a retrospective study 48
null 47
Neuropharmacology and behavior in planaria: translations to mammals 47
Interaction between cholinergic and catecholaminergic system in Alzheimer's disease and mild cognitive impairment 46
Safinamide improves executive functions in fluctuating Parkinson's disease patients. an exploratory study 45
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment. Italian multicentre survey of 905 patients with longterm follow-up 45
Action observation with dual task for improving cognitive abilities in Parkinson’s disease. a pilot study 45
Totale 6.682
Categoria #
all - tutte 25.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.958


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020937 0 0 0 0 0 0 291 219 206 106 57 58
2020/2021646 59 70 30 39 30 90 23 56 70 112 43 24
2021/20221.440 26 74 145 49 174 69 31 143 112 104 210 303
2022/20231.508 297 328 67 165 142 158 15 76 153 16 54 37
2023/2024791 55 131 32 81 51 105 33 46 5 100 74 78
2024/2025708 74 79 148 65 150 175 17 0 0 0 0 0
Totale 8.328